Cresco Labs Inc. (CL.CN) Financials

CL.CN Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2025 1.6 billion 1.3 billion
Sept. 30, 2025 1.8 billion 1.3 billion
June 30, 2025 1.8 billion 1.3 billion
March 31, 2025 2.0 billion 1.4 billion

CL.CN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 25.7 million ?
Sept. 30, 2025 -1.9 million 3.2 million
June 30, 2025 -6.1 million 3.5 million
March 31, 2025 33.6 million 3.9 million

CL.CN Net Income

No data available :(

CL.CN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 124.7 million 767.9 million 197.1 million
Sept. 30, 2025 63.2 million 779.4 million 344.4 million
June 30, 2025 199.5 million 826.5 million 339.8 million
March 31, 2025 223.1 million 880.1 million 369.2 million

CL.CN Shares Outstanding

No data available :(

CL.CN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 12.6 million - 84.1 million -
Sept. 30, 2025 10.5 million - 82.4 million -
June 30, 2025 18.1 million - 78.7 million 4.8 million
March 31, 2025 10.1 million - 93.4 million -

CL.CN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 237.2 million 125.2 million
Sept. 30, 2025 229.6 million 119.1 million
June 30, 2025 222.6 million 109.4 million
March 31, 2025 238.0 million 125.1 million

CL.CN

Price: CA$1.24

52 week price:
0.60
3.12

Earnings Per Share: -0.21 CAD

P/E Ratio: -6

Exchange: CNQ

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 429.0 million

Links: